Clinical Trials in Texas
Here are the 6 most popular medical studies in Texas Clinical Trials
PARP Inhibitor
Selumetinib + Olaparib or Selumetinib for Ovarian and Endometrial Cancers
Recruiting1 awardPhase 2
Oklahoma City, Oklahoma
This trial studies treating recurrent/persistent ovarian/endometrial cancer with RAS mutation with selumetinib+olaparib to increase tumor shrinkage & stability compared to selumetinib alone.
T cell Therapy
Posoleucel for Viral Infections
Recruiting0 awardsPhase 2 & 3
Dallas, Texas
“ Cure for HSV-2. I have been dealing with CFS for 3 years now. Age 80. Never been a drinker or smoker. CFS seems to be getting worse. Huge CRP labs. Tested positive for EBV in 3 different simultaneous tests. Chemical engineer. Widowed.”
PatientReceived no prior treatments
Monoclonal Antibodies
Dato-DXd + Pembrolizumab for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Chandler, Arizona
This trial will compare the effectiveness of a new cancer drug, datopotamab deruxtecan, when used with pembrolizumab versus pembrolizumab alone in patients with advanced lung cancer.
Popular filter options for Texas Clinical Trials trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Monoclonal Antibodies
Tildrakizumab for Psoriatic Arthritis
Recruiting2 awardsPhase 3
Tomball, Texas
“ I have tried very many different drugs and therapy to help my situation but nothing seems to work. I just want to be pain free and able to use my hand again. I would love to be able to go back to work. Someday soon hopefully.”
PatientReceived 1 prior treatment
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Monoclonal Antibodies
Tildrakizumab for Psoriatic Arthritis
Recruiting2 awardsPhase 3
Tomball, Texas
“ I have tried very many different drugs and therapy to help my situation but nothing seems to work. I just want to be pain free and able to use my hand again. I would love to be able to go back to work. Someday soon hopefully.”
PatientReceived 1 prior treatment
JAK Inhibitor
Ruxolitinib + Chemotherapy for Acute Lymphoblastic Leukemia
Recruiting1 awardPhase 2
Dallas, Texas
This trial is testing a new cancer drug, ruxolitinib, in combination with standard chemotherapy to treat B-cell acute lymphoblastic leukemia. The study will first find the best dose of ruxolitinib to use with chemotherapy, then test how well the combination works at that dose.
View More Texas Clinical Trials Trials
See another 84 many medical studies focused on Texas Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.